Optimized Self-Replicating RNA Enable Clinical Applications for Multiplexed Vaccines & Vectorized Biotherapeutics

• Optimizing self-replicating RNA vectors and manufacturing drive increases in immunogenicity and safety for a best-in-class therapeutic index
• Increased therapeutic index enable vaccines that target multiple respiratory pathogens and shorten development cycles
• srRNA are proving to enable a new class of vectorized biotherapeutics that enable multiplexed products with controllable PK profiles that can be re-dosed

Speakers:

Nathaniel Wang

Chief Executive Officer & Co-Founder

Replicate Bioscience